Co-Q10 Plus
Natural health product licensed in Canada
- Licence holder
- A.N. Tyler Holdings Ltd.
- NPN or DIN-HM
- 80006322
- Status
- Active licence
- Licence date
- 27 June 2008
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Potassium: up to 120 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ubidécarénone | 15 mg | Not calculated |
| Crataegus oxyacantha Source : Baie(s) Potency : 1.8 % vitexin-4 rhamnoside | 100 mg | Not calculated |
| Potassium Source : Citrate de potassium | 30 mg | 120,000 µg |
| Ginkgo biloba Source : Feuille(s) Potency : 24 % Ginkgo heterosides | 20 mg | Not calculated |
| Acide 2-aminoéthanesulfonique | 300 mg | Not calculated |
Non-medicinal ingredients
L-leucine, Dioxyde de silicium, Hypromellose, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 2 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Helps to support and maintain healthy cardiac function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health practitioner prior to use if you have kidney disorder, autoimmune deficiency, a heart condition or if you are taking diuretics or any other prescription medication. Consult a health care practitioner prior to use if you are taking medication/natural health products for diabetes and/or seizures.
- Contre-indications
Do not use if you are pregnant or breastfeeding. Do not use 7 days before or after surgery. Do not use if taking blood pressure or cholesterol lowering medications. Take a few hours before or a few hours after taking other medications. Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding.
Source
Official Health Canada record, licence 80006322
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.